Packed with Japanese Max Dose L-Glutathione + Sea Buckthorn + CoQ10 in SMART plant-based capsules that actually deliver results
The primary endpoint of IIH EVOLVE will assess efficacy of Presendin to reduce intracranial pressure (ICP) over 24 weeks compared to placebo
Currently, this product is available in the following states: AK, AZ, CO, CT, DE, FL, GA, HI, ID, IL, IA, KS, KY, LA, ME, MD, MA, MI, MN, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SD, TN, TX, UT, VT, VA, WA, WI, and WY
TRIUMPH-1 and TRIUMPH-2 are the pivotal trials
Review the tirzepatide dosing guide for protocol details that apply to both formulations